Altered expressions of CCN1/CYR61, CCN2/CTGF, CCN3/NOV, and CCN4/WISP1 were found to correlate with clinical features, including venous invasion, cellular differentiation, TNM staging for malignant tumors, disease-free survival, and overall survival in HCC [25]. The gene discussed is CCN2; the disease is cancer.